T cell receptor-therapy in HBV-related hepatocellularcarcinoma

OncoImmunology

Volumn 4, Issue 6, 2015, Pages

  Bertoletti, Antonio ^a,b,c   Brunetto, Maurizia ^d   Maini, Mala K ^e   Bonino, Ferruccio ^d   Qasim, Waseem ^e   Stauss, Hans ^e  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY HOSPITAL OF PISA   (Italy)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

HBV; Hepatocellularcarcinoma; T cell therapy

Indexed keywords

T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN;

ARTICLE; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CELL THERAPY; CHRONIC INFLAMMATION; ELECTROPORATION; HEPATITIS; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; METASTASIS; NONHUMAN; PROTEIN EXPRESSION; TUMOR VOLUME; VIRUS REPLICATION;

EID: 84944445841     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1008354     Document Type: Article

References (10)

1. Sung W-K, Zheng H, Li S, Chen R, Liu X, Li Y, Lee NP, Lee WH, Ariyaratne PN, Tennakoon C et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Gen 2012; 44:765-9; PMID: 22634754; http://dx.doi.org/10.1038/ng.2295
2. Gehring AJ, Ho ZZ, Tan AT, Aung MO, Lee KH, Tan KC, Lim SG, Bertoletti A. Profile of tumor antigenspecific CD8 T cells in patients with hepatitis B virusrelated hepatocellular carcinoma. Gastroenterology 2009; 137:682-90; PMID:19394336; http://dx.doi. org/10.1053/j.gastro.2009.04.045
3. Parkhurst MR, Yang JC, Langan RC, Dudley ME, Nathan D-AN, Feldman SA, Davis JL, Morgan RA, Merino MJ, Sherry RM et al. T cells targeting carcinoembryonic antigenCan mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol Ther 2009; 19:620-6; PMID: 21157437; http://dx.doi.org/10.1038/mt.2010.272
4. Ghorashian S, Veli�a P, Chua I, McNicol AM, Ben Carpenter, Holler A, Nicholson E, Ahmadi M, Zech M, Xue S-A et al. CD8 T cell tolerance to a tumorassociated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor. J Immunol 2014:1401703; PMID: 25539815; http://dx.doi. org/10.4049/jimmunol.1401703.
5. Gehring AJ, Xue S-A, Ho ZZ, Teoh D, Ruedl C, Chia A, Koh S, Lim SG, Maini MK, Stauss H et al. Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. J Hepatol 2011; 55:103-10; PMID:21145860; http://dx.doi.org/10.1016/j. jhep.2010.10.025
6. Krebs K, B�ttinger N, Huang LR, Chmielewski M, Arzberger S, Gasteiger G, J�ger C, Schmitt E, Bohne F, Aichler M et al. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice. Gastroenterology 2013; 145:456-65; PMID:23639914; http://dx.doi. org/10.1053/j.gastro.2013.04.047
7. Qasim W, Brunetto M, Gehring AJ, Xue S-A, Schurich A, Khakpoor A, Zhan H, Ciccorossi P, Gilmour K, Cavallone D et al. Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient. J Hepatol 2015; 62:486-92; PMID:25308176; http://dx.doi.org/ 10.1016/j.jhep.2014.10.001
8. Koh S, Shimasaki N, Suwanarusk R, Ho ZZ, Chia A, Banu N, Wu Howland S, Ong ASM, Gehring AJ, Stauss H et al. A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus. Mol Ther Nucleic Acids 2013; 2:e114; PMID:23941866; http://dx.doi.org/ 10.1038/mtna.2013.43
9. Lai Q, Avolio AW, Lerut J, Singh G, Chan SC, Berloco PB, Tisone G, Agnes S, Chok KS, Sharr W et al. Recurrence of hepatocellular cancer after liver transplantation: The role of primary resection and salvage transplantation in East and West. J Hepatol 2012; 57:974-9; PMID:22771712; http://dx.doi.org/ 10.1016/j.jhep.2012.06.033
10. Faria LC, Gigou M, Roque Afonso AM, Sebagh M, Roche B, Fallot G, Ferrari TCA, Guettier C, Dussaix E, Castaing D et al. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation. Gastroenterology 2008; 134:1890-9; PMID:18424269; http://dx.doi. org/10.1053/j.gastro.2008.02.064